Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This introduction explains the 5-year rule for Roth IRAs and how it affects qualified withdrawals and tax treatment.
21,792 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
The S&P 500 has slipped from its January peak, creating a dilemma for investors: chase a rebound or wait for more cla...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...
Rumors swirl about SpaceX planning an IPO at a staggering $1.75 trillion. This article breaks down what that would me...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...
Himax (HIMX) faces a pivotal year as AR/VR, automotive displays, and smartphone drivers shape demand. This Q1 2026 ea...
eXp World Holdings posts strong first-quarter results as agent productivity rises and it taps NextHome to broaden its...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
The AI boom isn’t just about memory chips anymore. A broader wave of demand is lifting compute, software, and data in...
Nvidia is poised to deliver another strong earnings quarter, but history shows a big print doesn’t always move the st...
As BioHarvest gears up for its Q1 2026 earnings, investors seek clarity on revenue momentum, margins, and the path to...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...